期刊文献+

分子诊断质量控制面临的问题 被引量:5

下载PDF
导出
摘要 与临床检验其他项目相比,分子诊断检测项目的质量控制面临很多挑战。如缺乏质量控制物质,缺乏误差相关的数据和缺乏适当的质控方法等。对此,临床实验室可借鉴传统的质量控制统计分析法,并开发适于分子诊断检测的质控方法,加强分子诊断仪器的质量控制数据采集和输出系统的研发,研究出具体的分子诊断质控技术,并提供相应的操作标准和指南。
出处 《临床检验杂志》 CAS CSCD 北大核心 2012年第6期466-467,共2页 Chinese Journal of Clinical Laboratory Science
  • 相关文献

参考文献13

  • 1SACGHS. U.S. System of oversight of genetic testing: a response to the charge of the secretary of health and human services [ S ]. Report of the Secretary Advisory Committee on Genetics, Health, and Soci- ety, 2008.
  • 2CDC. Review of proficiency testing services for clinical laboratories in the United States : final report of a technical working group [ S ]. Centers for Disease Control and Prevention,2008.
  • 3CDC. Draft genetic test review : cystic fibrosis analytic validity [ S ]. Centers for Disease Control and Prevention, 2007.
  • 4Dequeker E, Ramsden S, Grody WW, et al. Quality control in mo- lecular genetic testing[J]. Nat Rev Genet, 2001,9(2) : 717-723.
  • 5Clark A, Rundell. Upgrading quality control in molecular diagnostics [ S ]. http://www, ivdtechnology, corn/article/upgrading-quality- control-molecular-diagnostics.
  • 6Berwouts S, Gordon JT, Rundell CA, et al. Evaluation and use of a synthetic quality control material, included in the European external quality assessment scheme for cystic fibrosis [ J ]. Hum Mutat, 2008, 29(8) :1063-1070.
  • 7Liang SL, Lin MT, Hafez M J, et al. Application of traditional clinical pathology quality control techniques to molecular pathology [ J ], J Mol Diagn, 2008,10 (2) :142-146.
  • 8Westgard JO. Basic QC Practices[ M]. 3rd edition, Madison: WI, 2010.
  • 9Westgard JO, Groth T, Aronsson T, et al. Combined Shewhart-cu- sum control chart for improved quality control in clinical chemistry [J]. Clin Chem, 1977, 23(10) : 1881-1887.
  • 10CDC. Genetic testing reference materials coordination program[ S]. Centers for Disease Control and Prevention,2007.

同被引文献56

  • 1李金明.实时荧光PCR技术[M].北京:人民军医出版社,2014:65-70.
  • 2Li-Wan-Po A. Pharmacogenetics and personalized medicine[ J]. J Clin Pharm Ther, 2012, 37(6) : 617-619.
  • 3Cymet T. Evidence-based medicine:how it is different from what we have always done? [J]. Md Med, 2012, 13(1) : 10.
  • 4Campuzano O, Alcalde M, Berne P, et al. Role of novel DSP_p. Q986X genetic vm'iation in arrhythmogenic right ventricular eardiomyopathy [ J ]. Eur J M ed Genet, 2013,56 ( 10 ) : 541-545.
  • 5Hermida JS, Arnalsteen-Dassonvalle E, Kubala M, et al. Dual phenotypic transmission in Brugada syndrome [ J ]. Arch of Cardiovasc Dis, 2013, 106(6-7) : 366-372.
  • 6Murakami M, Nakamura K, Kusano KF, et al. Efficacy of low- dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation[ J]. J Cardiovase Pharmacol, 2010, 56(4) : 389-395.
  • 7Zhang Y, Wang J, Chang S, et al. The SCN5A Mutation A1180V is Associated With Electrocardiographic Features of LQT3 [ J ]. Pediatr Cardiol, 2014, 35 (2) : 295-300.
  • 8Spyridopoulos I, yon Zglinicki T. Telomere length predicts cardiovascular disease[ J]. BMJ, 2014, 349: g4373.
  • 9Rajagopal SK, Ma Q, Obler D, et al. Spectrum of heart disease associated with murine and human GATA4 mutation [ J ]. J Mol Cell Cardiol, 2007, 43 (6) : 677-685.
  • 10Cao Q, Wang x, Jia L, et al. Inhibiting DNA Methylation by 5- aza-2'-deoxycytidine Ameliorates Atherosclerosis Through Suppressing Macrophage Inflammation[ J]. Endocrinology, 2014, 155(12) : 4925-4938.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部